Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  therapeutic allogeneic cytotoxic T lymphocytes
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-5 of 5 for your search:
Start Over
Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2225.00, NCI-2010-00108, K12CA076930, FHCRC-2225.00, IR-6881, BMS-CA184-062, NCT00871481
Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors
Phase: Phase I
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: 93-0426.cc, UCHSC-COMIRB-93426, NCI-T94-0065O, T94-0065, NCT00002572
Cellular Immunotherapy Study for Brain Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: UCLA 07-09-008, R01CA125244, NCT01144247
Allogeneic Stem Cell Transplantation for Advanced Neuroblastoma Using MHC Mismatched Related Donors
Phase: Phase I
Type: Treatment
Status: Closed
Age: 6 months to 17 years
Sponsor: Other
Protocol IDs: STALLO, NCT01462396
Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE)
Phase: Phase I
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: 26374-VIRAGE, VIRAGE, NCT01070797
Start Over